Active Shortage Injection Oncology
Azacitidine Injection · 2,093 days since initial FDA posting
Brand: AZACITIDINE
FDA lists Azacitidine Injection as Active Shortage (Meitheal Pharmaceuticals, Inc.).
Availability on file: Available
Azacitidine Injection: Active Shortage
Available Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Azacitidine Injection
- Manufacturer
- Meitheal Pharmaceuticals, Inc.
- Dosage Form
- Injection
- Presentation
- Azacitidine, Injection, 100 mg/30 mL (NDC 71288-115-30)
- Package NDC
- 71288-115-30
Status & Timeline
- Status
- Active Shortage
- Availability
- Available
- First Reported
- Dec 18, 2020
- Last Updated
- Aug 19, 2025
- Therapeutic Category
- Oncology
Row fields from the FDA Drug Shortages database via openFDA.
Nearby, Other Azacitidine Shortage Records
Azacitidine Injection
Eugia US LLC
Injection
Azacitidine Injection
Fresenius Kabi USA, LLC
Injection
Azacitidine Injection
Bristol Myers Squibb Co.
Injection
Azacitidine Injection
Accord Healthcare Inc.
Injection
Azacitidine Injection
Dr. Reddy's Laboratories, Inc.
Injection
Azacitidine Injection
Teva Pharmaceuticals USA, Inc.
Injection